Cardiac Biomarkers After Marathon Running and Coronary Atherosclerosis
NCT ID: NCT03738631
Last Updated: 2024-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
43 participants
OBSERVATIONAL
2018-08-17
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Troponin Fragmentation After Heavy Physical Exercise The MaraCat2 Study
NCT06000930
Cardiovascular Effects of Marathon Running
NCT04738877
Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study
NCT07033624
Coronary Arteriosclerosis in Patients With Acute Ischemic Stroke
NCT00701818
Biomarkers in Acute Cardiac Care
NCT02355457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Under 35 years
No interventions assigned to this group
Over 44 years
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant of Paavo Nurmi Marathon 2018
* Informed consent signed
Exclusion Criteria
* existing coronary artery disease
35 Years
90 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Turku
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juhani Airaksinen
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Turku University Hospital, Heart Center
Turku, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T171/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.